Arie Perry Selected Research

Meningioma (Meningiomas)

6/2022	Low-Risk Meningioma: Initial Outcomes from NRG Oncology/RTOG 0539.
1/2022	Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.
1/2022	Molecular neuropathology of brain-invasive meningiomas.
12/2020	A Prognostic Gene-Expression Signature and Risk Score for Meningioma Recurrence After Resection.
11/2020	The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies.
1/2020	DNA methylation profiling demonstrates superior diagnostic classification to RNA-sequencing in a case of metastatic meningioma.
1/2019	Molecular and translational advances in meningiomas.
6/2018	Salvage therapy outcomes for atypical meningioma.
1/2018	Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
1/2018	Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arie Perry Research Topics

Disease

104	Neoplasms (Cancer) 01/2022 - 01/2002
33	Glioma (Gliomas) 01/2022 - 09/2007
27	Meningioma (Meningiomas) 06/2022 - 05/2002
21	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 12/2002
20	Glioblastoma (Glioblastoma Multiforme) 10/2022 - 07/2004
14	Neurofibrosarcoma (MPNST) 01/2020 - 02/2004
10	Brain Neoplasms (Brain Tumor) 11/2020 - 12/2002
8	Oligodendroglioma 12/2017 - 05/2003
7	Primitive Neuroectodermal Tumors (PNET) 01/2021 - 01/2006
7	Neoplasm Metastasis (Metastasis) 03/2020 - 02/2004
7	Medulloblastoma 01/2019 - 07/2004
7	Ependymoma 07/2013 - 05/2002
5	Sarcoma (Soft Tissue Sarcoma) 10/2021 - 05/2008
4	Neurilemmoma (Schwannoma) 01/2016 - 12/2005
4	Necrosis 02/2015 - 03/2006
3	Disease Progression 01/2020 - 01/2006
3	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2020 - 01/2010
3	Ganglioglioma 01/2018 - 09/2011
3	Neurofibroma 01/2017 - 12/2005
3	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2017 - 09/2007
3	Central Nervous System Neoplasms 07/2005 - 05/2002
2	Hemangioma (Angioma) 01/2021 - 08/2008
2	Neurocytoma 01/2020 - 07/2004
2	Epilepsy (Aura) 10/2019 - 01/2018
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2019 - 01/2011
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2018 - 12/2017
2	Chordoma 05/2017 - 11/2014
2	Meningitis 05/2017 - 10/2016
2	Gliosarcoma 10/2016 - 05/2013
2	Monosomy 01/2016 - 05/2008
2	Carcinogenesis 12/2012 - 09/2010
2	Typical Teratoid Rhabdoid Tumor 12/2012 - 05/2005
2	Adenocarcinoma 12/2010 - 07/2006
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 09/2010 - 11/2004
2	Optic Nerve Glioma 03/2008 - 09/2007
2	Ewing Sarcoma (Sarcoma, Ewing) 06/2007 - 07/2005
2	Peripheral Primitive Neuroectodermal Tumors (Peripheral Neuroectodermal Tumor) 06/2007 - 07/2005
2	Peripheral Nervous System Neoplasms 12/2005 - 02/2004

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2002
21	Biological ProductsIBA 01/2022 - 05/2002
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2005
10	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 05/2002
9	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 09/2011
9	Histones (Histone)IBA 03/2020 - 04/2013
8	ErbB Receptors (EGF Receptor)IBA 01/2021 - 12/2005
7	Phosphotransferases (Kinase)IBA 10/2021 - 07/2009
6	Neurofibromin 2 (Merlin)IBA 01/2022 - 05/2002
6	Neurofibromin 1 (Neurofibromin)IBA 01/2020 - 09/2003
5	Temozolomide (Temodar)FDA LinkGeneric 12/2017 - 03/2008
4	MucinsIBA 01/2021 - 11/2004
4	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2011
4	AntigensIBA 12/2016 - 01/2005
4	ParaffinIBA 05/2015 - 12/2002
4	AntibodiesIBA 03/2013 - 10/2004
4	Tumor Suppressor Protein p14ARF (p14ARF)IBA 05/2012 - 11/2004
3	Hormones (Hormone)IBA 01/2021 - 11/2012
3	Lysine (L-Lysine)FDA Link 01/2020 - 04/2013
3	2,6-dinitrotoluene (DNT)IBA 01/2020 - 01/2010
3	SteroidsIBA 10/2016 - 02/2007
3	LigandsIBA 04/2016 - 02/2004
3	Small Interfering RNA (siRNA)IBA 09/2015 - 03/2006
3	Formaldehyde (Formol)FDA Link 05/2015 - 01/2006
3	Genetic Markers (Genetic Marker)IBA 10/2014 - 11/2004
3	Cyclic AMP (AMP, Cyclic)IBA 12/2008 - 01/2007
3	OligonucleotidesIBA 03/2006 - 08/2002
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 02/2004
2	SynaptophysinIBA 01/2021 - 03/2007
2	DesminIBA 01/2021 - 01/2020
2	Keratins (Keratin)IBA 12/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 06/2007
2	Mutant Proteins (Protein, Mutant)IBA 12/2017 - 05/2013
2	Amylases FDA Link 08/2017 - 07/2005
2	Rituximab (Mabthera)FDA Link 10/2016 - 09/2011
2	CateninsIBA 10/2016 - 03/2011
2	Pharmaceutical PreparationsIBA 04/2016 - 03/2008
2	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2015 - 12/2005
2	Mucin-1 (CA 15-3 Antigen)IBA 09/2015 - 11/2004
2	NestinIBA 08/2015 - 01/2005
2	Tumor Biomarkers (Tumor Markers)IBA 06/2015 - 08/2005
2	PlatinumIBA 09/2014 - 01/2009
2	MicroRNAs (MicroRNA)IBA 08/2014 - 12/2012
2	Bevacizumab (Avastin)FDA Link 07/2014 - 04/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 08/2008
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2013 - 01/2013
2	Complementary DNA (cDNA)IBA 11/2012 - 07/2004
2	Cyclin-Dependent Kinase Inhibitor p16IBA 05/2012 - 03/2006
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2012 - 08/2003
2	beta CateninIBA 09/2010 - 07/2004
2	Cadherins (E-Cadherin)IBA 09/2010 - 07/2005
2	Glial Fibrillary Acidic ProteinIBA 03/2009 - 05/2008
2	RolipramIBA 12/2008 - 01/2007
2	Messenger RNA (mRNA)IBA 11/2008 - 12/2005
2	Periodic AcidIBA 06/2007 - 07/2005

Therapy/Procedure

32	Therapeutics 10/2022 - 07/2004
11	Radiotherapy 01/2020 - 04/2004
10	Drug Therapy (Chemotherapy) 10/2019 - 04/2004
3	Immunotherapy 01/2022 - 11/2016
2	Neoadjuvant Therapy 01/2021 - 01/2017
2	Ventriculoperitoneal Shunt 03/2020 - 05/2017
2	Operative Surgical Procedures 08/2007 - 04/2004